Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing extra-hepatic metastases during a period of time
go back to main search page
Accession:CMO:0003785 term browser browse the term
Definition:The number of subjects developing extra-hepatic metastases in a study population during a certain period compared to the total number of subjects in the study population, expressed as a percentage. An extra-hepatic metastasis is a neoplasm transferred from one organ or part of the body to another (not liver) remote from the primary site.
Synonyms:exact_synonym: incidence of extra-hepatic metastases
 xref: PMID:10431686



show annotations for term's descendants           Sort by:

Related Phenotype Data for Term "percentage of study population developing extra-hepatic metastases during a period of time" (CMO:0003785)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        percentage of study population developing extra-hepatic metastases during a period of time 0
paths to the root